Policy Number | Policy Title |
---|
CP.PHAR.345 | Abaloparatide (Tymlos) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.355 | Abemaciclib (Verzenio) (PDF)Ciprofloxacin/Fluocinolone (Otovel) (PDF) |
CP.PHAR.84 | Abiraterone (Zytiga, Yonsa) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.578 | Abrocitinib (Cibinqo) (PDF) |
CP.PHAR.230 | AbobotulinumtoxinA (Dysport) (PDF) |
CP.PHAR.366 | Acalabrutinib (Calquence) (PDF) Effective Date: 5/1/2025 |
CP.PMN.210 | Acyclovir Buccal Tablet (Sitavig) (PDF) |
CP.PHAR.605 | Adagrasib (Krazati) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.142 | Adefovir (Hepsera) (PDF) |
CP.PHAR.635 | ADAMTS13, Recombinant-krhn (Adzynma) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.229 | Ado-Trastuzumab Emtansine (Kadcyla) (PDF) |
CP.PHAR.468 | Aducanumab-avwa (Aduhelm) (PDF) |
CP.PHAR.444 | Afamelanotide (Scenesse) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.678 | Afamitresgene Autoleucel (Tecelra) (PDF) |
CP.PHAR.298 | Afatinib (Gilotrif) (PDF) |
CP.PHAR.184 | Aflibercept (Eylea, Eylea HD), Aflibercept-yszy (Opuviz), Aflibercept-jbvf (Yesafili), Aflibercept-mrbb (Ahzantive), Aflibercept-abzv (Enzeevu), Aflibercept-ayyh (Pavblu) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.158 | Agalsidase Beta (Fabrazyme) (PDF) |
CP.PMN.138 | Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) |
CP.PHAR.369 | Alectinib (Alecensa) (PDF) |
CP.PHAR.243 | Alemtuzumab (Lemtrada) (PDF) |
CP.PMN.88 | Alendronate (Binosto, Fosamax Plus D) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.160 | Alglucosidase Alfa (Lumizyme) (PDF) Effective 5/1/2025 |
CP.PHAR.562 | Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.563 | Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.94 | Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)External Link Effective Date: 3/1/2025 |
CP.PHAR.430 | Alpelisib (Piqray, Vijoice) (PDF) |
CP.PMN.89 | Amantadine ER (Gocovri, Osmolex ER) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.190 | Ambrisentan (Letairis) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.411 | Amifampridine (Firdapse) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.401 | Amikacin (Arikayce) (PDF) |
CP.PMN.236 | Amisulpride (Barhemsys) (PDF) |
CP.PHAR.544 | Amivantamab-vmjw (Rybrevant) (PDF) |
CP.PHAR.551 | Anifrolumab-fnia (Saphnelo) (PDF) |
CP.PHAR.217 | Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.564 | Antithrombin III (ATryn, Thrombate III) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.506 | Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) |
CP.PCH.45 | Apalutamide (Erleada) (PDF) |
CP.PHAR.488 | Apomorphine (Apokyn, Kynmobi) (PDF) |
CP.PMN.19 | Aprepitant (Aponvie, Emend, Cinvanti), Fosaprepitant (Emend for injection, Focinvez) (PDF) |
CP.PHAR.676 | Aprocitentan (Tryvio) (PDF) |
CP.PHAR.510 | Arimoclomol (Miplyffa) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.290 | Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF) |
CP.PCH.37 | Aripiprazole Orally Disintegrating Tablet (PDF) Effective Date: 3/1/2025 |
CP.PMN.300 | Aripiprazole Orally Disintegrating Tablet, Oral Film (Opipza) (PDF) Effective Date: 3/1/2025 |
CP.PCH.37 | Aripiprazole ODT (Abilify) (PDF) |
CP.PMN.35 | Armodafinil (Nuvigil) (PDF) |
CP.PHAR.565 | Asciminib (Scemblix) (PDF) Effective Date: 5/1/2025 |
CP.PMN.15 | Asenapine (Saphris, Secuado) (PDF) |
CP.PHAR.328 | Asfotase Alfa (Strensiq) (PDF) |
CP.PHAR.328 | Asfotase Alfa (Strensiq) (PDF) |
CP.PMN.20 | Aspirin/Dipyridamole (Aggrenox) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.235 | Atezolizumab (Tecentriq), Atezolizumab-Hyaluronidase (Tecentriq Hybreza) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.602 | Atidarsagene autotemcel (Lenmeldy) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.566 | Atogepant (Qulipta) (PDF)External Link |
CP.PHAR.641 | Avacincaptad pegol (Izervay) (PDF) |
CP.PHAR.521 | Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) |
CP.PHAR.515 | Avacopan (Tavneos) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.521 | Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.454 | Avapritinib (Ayvakit) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.130 | Avatrombopag (Doptelet) (PDF) |
CP.PHAR.333 | Avelumab (Bavencio) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.691 | Axatilimab-csfr (Niktimvo) (PDF) |
CP.PHAR.362 | Axicabtagene Ciloleucel (Yescarta) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.100 | Axitinib (Inlyta) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.387 | Azacitidine (Onureg, Vidaza) (PDF) |
HIM.PA.119 | Azelaic Acid (Finacea Topical Gel/Foam) (PDF) |
CP.PHAR.209 | Aztreonam (Cayston) (PDF) |
CP.PHAR.149 | Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) |
CP.PMN.185 | Baloxavir Marboxil (Xofluza) (PDF) |
CP.PMN.212 | Bedaquiline (Sirturo) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.469 | Belantamab Mafodotin-blmf (Blenrep) (PDF) |
CP.PHAR.201 | Belatacept (Nulojix) (PDF) |
CP.PHAR.88 | Belimumab (Benlysta) (PDF) |
CP.PHAR.311 | Belinostat (Beleodaq) (PDF) |
CP.PHAR.552 | Belumosudil (Rezurock) (PDF) |
CP.PHAR.553 | Belzutifan (Welireg) (PDF) |
CP.PMN.237 | Bempedoic Acid (Nexletol), Bempedoic Acid/Ezetimibe (Nexlizet) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.307 | Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) |
HIM.PA.SP70 | Benralizumab (Fasenra) (PDF) Effective Date: 3/1/2025 |
CP.PMN.90 | Benznidazole (PDF) Effective Date: 3/1/2025 |
CP.PMN.293 | Berdazimer (Zelsuvmi) (PDF) |
CP.PHAR.592 | Beremagene geperpavec-svdt (Vyjuvek) (PDF) |
HIM.PA.169 | Berotralstat (Orladeyo) (PDF) |
CP.PHAR.143 | Betaine (Cystadane) (PDF) |
CP.PMN.182 | Betamethasone Dipropionate Spray (Sernivo) (PDF) |
CP.PHAR.545 | Betibeglogene Autotemcel (Zynteglo) (PDF) |
CP.PHAR.93 | Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF) |
CP.PHAR.75 | Bexarotene (Targretin Capsules, Gel) (PDF) |
CP.PHAR.300 | Bezlotoxumab (Zinplava) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.486 | Bimatoprost Implant (Durysta) (PDF) |
CP.PHAR.50 | Binimetinib (Mektovi) (PDF) |
HIM.PA.SP60 | Biologic and Non-biologic DMARDs (PDF) Effective Date: 5/1/2025 |
CP.PHAR.669 | Birch Triterpenes (Filsuvez) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.312 | Blinatumomab (Blincyto) (PDF)
|
CP.PHAR.410 | Bortezomib (Velcade) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.191 | Bosutinib (Bosulif) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.105 | Bosutinib (Bosulif) (PDF) |
HIM.PA.103 | Brand Name Override and Non-Formulary Medications (PDF) |
CP.PHAR.303 | Brentuximab Vedotin (Adcetris) (PDF) |
CP.PHAR.417 | Brexanolone (Zulresso) (PDF) |
CP.PMN.68 | Brexpiprazole (Rexulti) (PDF) |
CP.PHAR.472 | Brexucabtagene Autoleucel (Tecartus) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.342 | Brigatinib (Alunbrig) (PDF) |
CP.PMN.192 | Brimonidine Tartrate (Mirvaso) |
HIM.PA.15 | Brinzolamide/Brimonidine (Simbrinza) (PDF) |
CP.PMN.297 | Brivaracetam (Briviact) (PDF) |
CP.PHAR.445 | Brolucizumab-dbll (Beovu) (PDF) Effective Date: 5/1/2025 |
CP.PMN.294 | Budesonide (Eohilia, Uceris) (PDF) |
CP.PHAR.572 | Budesonide (Tarpeyo) (PDF) Effective Date: 3/1/2025 |
CP.PMN.82 | Buprenorphine (Subutex) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.289 | Buprenorphine Injection (Sublocade, Brixadi) (PDF) Effective Date: 5/1/2025 |
CP.PMN.81 | Buprenorphine/Naloxone (Suboxone, Zubsolv) (PDF) Effective Date: 3/1/2025 |
CP.PCH.12 | Bupropion/Naltrexone (Contrave) (PDF) |
CP.PHAR.11 | Burosumab-twza (Crysvita) (PDF) |
HIM.PA.46 | Butorphanol Nasal Spray (PDF) |
HIM.PA.170 | C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) |
CP.PHAR.316 | Cabazitaxel (Jevtana) (PDF) |
CP.PHAR.573 | Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.111 | Cabozantinib (Cabometyx, Cometriq) (PDF) Effective Date: 5/1/2025 |
CP.PMN.76 | Calcifediol (Rayaldee) (PDF) |
CP.PMN.181 | Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) |
CP.PHAR.246 | Canakinumab (Ilaris) (PDF) |
CP.PMN.164 | Cannabidiol (Epidiolex) (PDF) |
CP.PHAR.60 | Capecitabine (Xeloda) (PDF) |
CP.PHAR.663 | Capivasertib (Truqap) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.416 | Caplacizumab-yhdp (Cablivi) (PDF) |
CP.PHAR.494 | Capmatinib (Tabrecta) (PDF) |
CP.PMN.238 | Carbidopa/Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy) (PDF) |
CP.PHAR.309 | Carfilzomib (Kyprolis) (PDF) |
CP.PHAR.206 | Carglumic Acid (Carbaglu) (PDF) Effective Date: 5/1/2025 |
CP.PMN.91 | Cariprazine (Vraylar) (PDF) |
CP.PHAR.470 | Casimersen (Amondys 45) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.397 | Cemiplimab-rwlc (Libtayo) (PDF) |
CP.PMN.186 | Cenegermin-bkbj (Oxervate) (PDF) Effective Date: 3/1/2025 |
CP.PMN.231 | Cenobamate (Xcopri) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.422 | Cladribine (Mavenclad) (PDF) |
CP.PHAR.349 | Ceritinib (Zykadia) (PDF) |
CP.PHAR.338 | Cerliponase Alfa (Brineura) (PDF) |
CP.PHAR.317 | Cetuximab (Erbitux) (PDF) |
CP.PMN.239 | Chenodiol (Chenodal) (PDF) |
CP.PHAR.554 | Chlorambucil (Leukeran) (PDF) |
CP.PHAR.388 | Chloramphenicol Sodium Succinate (PDF) |
CP.PHAR.390 | Cholic Acid (Cholbam) (PDF) |
CP.PMN.24 | Ciclopirox Topical Solution 8% (PDF) Effective Date: 3/1/2025 |
CP.PHAR.533 | Ciltacabtagene Autoleucel (Carvykti) (PDF) |
CP.PHAR.61 | Cinacalcet (Sensipar) (PDF) |
CP.PHAR.567 | Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF) Effective Date: 5/1/2025 |
CP.PMN.248 | Ciprofloxacin/Dexamethasone (Ciprodex) (PDF) |
CP.PMN.249 | Ciprofloxacin/Fluocinolone (Otovel) (PDF) |
CP.PMN.257 | Clascoterone (Winlevi) (PDF) Effective Date: 3/1/2025 |
CP.PMN.54 | Clobazam (Onfi, Sympazan) (PDF) |
CP.PMN.92 | CNS Stimulants (PDF) Effective Date: 5/1/2025 |
CP.PHAR.380 | Cobimetinib (Cotellic) (PDF)Copanlisib (Aliqopa) (PDF) |
CP.PMN.123 | Colchicine (Colcrys, Lodoco) (PDF) Effective Date: 5/1/2025 |
CP.PMN.250 | Colesevelam (Welchol) (PDF) |
CP.PHAR.82 | Collagenase Clostridium Histolyticum (Xiaflex) (PDF)External Link |
CP.PCH.43 | Colonoscopy Preparation Products (PDF) |
CP.PMN.280 | Compounded Medications (PDF) |
CP.PMN.258 | Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) Effective Date: 3/1/2025 |
CP.PMN.214 | Continuous Glucose Monitors (PDF) Effective Date: 3/1/2025 |
CP.PHAR.357 | Copanlisib (Aliqopa) (PDF) |
CP.PHAR.385 | Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF) |
CP.PHAR.711 | Cosibelimab-Ipdl (Unloxcyt) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.203 | Cosyntropin (Cortrosyn) (PDF) Effective Date: 5/1/2025 |
CP.PMN.110 | Crisaborole (Eucrisa) (PDF) |
CP.PHAR.449 | Crizanlizumab-tmca (Adakveo) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.90 | Crizotinib (Xalkori) (PDF) |
CP.PHAR.664 | Crovalimab-akkz (PiaSky) (PDF) Effective Date: 3/1/2025 |
CP.PMN.48 | Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF) |
CP.PMN.130 | Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF) |
CP.PHAR.155 | Cysteamine oral (Cystagon, Procysbi) (PDF) |
CP.PHAR.277 | Cytomegalovirus Immune Globulin (CytoGam) (PDF) |
CP.PHAR.239 | Dabrafenib (Tafinlar) (PDF) |
CP.PHAR.399 | Dacomitinib (Vizimpro) (PDF) |
CP.PHAR.248 | Dalfampridine (Ampyra) (PDF) |
CP.PHAR.225 | Dalteparin (Fragmin) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.665 | Danicopan (Voydeya) (PDF) |
CP.PHAR.628 | Daprodustat (Jesduvroq) (PDF) |
CP.PCH.32 | Dapsone (Aczone Gel) (PDF) |
CP.PHAR.351 | Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF) |
CP.PHAR.310 | Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) |
CP.PHAR.236 | Darbepoetin Alfa (Aranesp) (PDF) |
CP.PHAR.435 | Darolutamide (Nubeqa) (PDF) |
HIM.PA.SP61 | Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir (Viekira Pak) (PDF) |
CP.PHAR.72 | Dasatinib (Sprycel, Phyrago) (PDF) |
CP.PHAR.352 | Daunorubicin/Cytarabine (Vyxeos) (PDF) |
CP.PHAR.651 | DaxibotulinumtoxinA-lanm (Daxxify) (PDF) |
CP.PHAR.479 | Decitabine/Cedazuridine (Inqovi) (PDF) |
CP.PHAR.145 | Deferasirox (Exjade, Jadenu) (PDF) |
CP.PHAR.147 | Deferiprone (Ferriprox) (PDF) |
CP.PHAR.146 | Deferoxamine (Desferal) (PDF) |
CP.PHAR.331 | Deflazacort (Emflaza) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.170 | Degarelix Acetate (Firmagon) (PDF) |
CP.PMN.115 | Delafloxacin (Baxdela) (PDF) |
CP.PHAR.593 | Delandistrogene Moxeparvovec-rokl (Elevidys) (PDF) |
CP.PHAR.693 | Denileukin Diftitox-cxdl (Lymphir) (PDF) |
CP.PHAR.58 | Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.214 | Desmopressin Acetate (DDAVP, Stimate, Nocdurna) (PDF) Effective Date: 5/1/2025 |
CP.PCH.42 | Deutetrabenazine (Austedo, Austedo XR) (PDF) |
CP.PHAR.418 | Dexrazoxane (Totect) (PDF) |
CP.PMN.284 | Dextromethorphan/Bupropion (Auvelity) (PDF) |
CP.PMN.284 | Dextromethorphan-bupropion (Auvelity) (PDF) |
CP.PMN.93 | Dextromethorphan-Quinidine (Nuedexta) (PDF) Effective Date: 3/1/2025 |
CP.PMN.216 | Diazepam Nasal Spray (Valtoco) (PDF)
|
CP.PMN.261 | Dichlorphenamide (Keveyis) (PDF) Effective Date: 3/1/2025 |
CP.PCH.28 | Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) |
CP.PHAR.249 | Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF) |
HIM.PA.58 | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (PDF) Effective Date: 3/1/2025 |
CP.PMN.141 | Dolasetron (Anzemet) (PDF) |
CP.PHAR.594 | Donanemab-azbt (Kinsunla) (PDF) |
CP.PHAR.212 | Dornase Alfa (Pulmozyme) (PDF) |
CP.PHAR.540 | Dostarlimab-gxly (Jemperli) (PDF) |
CP.PMN.175 | Doxepin (Silenor) (PDF) |
HIM.PA.147 | Doxepin (Silenor, Prudoxin, Zonalon) (PDF) |
CP.PMN.79 | Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF) |
HIM.PA.SP69 | Dupilumab (Dupixent) (PDF) Effective Date: 5/1/2025 |
CP.PMN.128 | Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) |
CP.PHAR.400 | Duvelisib (Copiktra) (PDF) |
CP.PHAR.177 | Ecallantide (Kalbitor) (PDF) |
CP.PHAR.97 | Eculizumab (Soliris) (PDF) |
CP.PHAR.343 | Edaravone (Radicava, Radicava ORS) (PDF) |
CP.PHAR.555 | Efgartigimod alfa, efgartigimod-hyaluronidase (Vyvgart, Vyvgart Hytrulo) (PDF)Elacestrant (Orserdu) Effective Date: 5/1/2025 |
CP.PMN.25 | Efgartigimod Alfa-fcab, Efgartigimod/Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.670 | Eflornithine (Iwilfin) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.623 | Elacestrant (Orserdu) (PDF) |
CP.PHAR.595 | Eladocagene Exuparvovec-tneq (Kebilidi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.688 | Elafibranor (Iqirvo) (PDF) |
CP.PHAR.136 | Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) (PDF)Elapegademase-lvlr (Revcovi) |
CP.PHAR.419 | Elapegademase-lvlr (Revcovi) (PDF) |
HIM.PA.SP62 | Elbasvir/Grazoprevir (Zepatier) (PDF) |
CP.PHAR.440 | Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.153 | Eliglustat (Cerdelga) (PDF) |
CP.PHAR.556 | Elivaldogene Autotemcel (Skysona) (PDF) |
CP.PHAR.162 | Elosulfase Alfa (Vimizim) (PDF) |
CP.PHAR.308 | Elotuzumab (Empliciti) (PDF) |
CP.PHAR.652 | Elranatamab-bcmm (Elrexfio) (PDF) |
CP.PHAR.180 | Eltrombopag (Alvaiz, Promacta) (PDF) Effective Date: 5/1/2025 |
CP.PMN.170 | Eluxadoline (Viberzi) (PDF) |
CP.PHAR.402 | Emapalumab-lzsg (Gamifant) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.370 | Emicizumab-kxwh (Hemlibra) (PDF) Effective Date: 3/1/2025 |
CP.PMN.235 | Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.363 | Enasidenib (Idhifa) (PDF) |
CP.PHAR.127 | Encorafenib (Braftovi) (PDF) |
CP.PHAR.455 | Enfortumab Vedotin-ejfv (Padcev) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.41 | Enfuvirtide (Fuzeon) (PDF) |
CP.PHAR.224 | Enoxaparin (Lovenox) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.712 | Ensartinib (Ensacove) (PDF) Effective Date: 3/1/2025 |
HIM.PA.08 | Entecavir (Baraclude) (PDF) |
CP.PHAR.441 | Entrectinib (Rozlytrek) (PDF) |
CP.PHAR.106 | Enzalutamide (Xtandi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.634 | Epcoritamab-bysp (Epkinly) (PDF) |
CP.PHAR.633 | Eplontersen (Wainua) (PDF) |
CP.PHAR.237 | Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) |
CP.PHAR.192 | Epoprostenol (Flolan, Veletri) (PDF) Effective Date: 3/1/2025 |
HIM.PA.SP64 | Eptinezumab-jjmr (Vyepti) (PDF) |
CP.PHAR.423 | Erdafitinib (Balversa) (PDF) |
HIM.PA.SP65 | Erenumab-aooe (Aimovig) (PDF) |
CP.PHAR.318 | Eribulin Mesylate (Halaven) (PDF) |
CP.PHAR.74 | Erlotinib (Tarceva) (PDF) |
CP.PHAR.301 | Erwinia Asparaginase (Rylaze) (PDF) |
CP.PMN.199 | Esketamine (Spravato) (PDF) |
CP.PMN.263 | Estradiol Vaginal Ring (Femring) (PDF) |
CP.PHAR.379 | Etelcalcetide (Parsabiv) (PDF) |
CP.PHAR.288 | Eteplirsen (Exondys 51) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.580 | Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.603 | Exagamglogene Autotemcel (Casgevy) (PDF) |
CP.PHAR.63 | Everolimus (Afinitor, Afinitor Disperz, Zortress) (PDF) Effective Date: 5/1/2025 |
HIM.PA.166 | Evinacumab-dgnb (Evkeeza) (PDF) Effective Date: 5/1/2025 |
HIM.PA.156 | Evolocumab (Repatha) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.603 | Exagamglogene Autotemcel (Casgevy) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.218 | Factor IX (Human, Recombinant) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.219 | Factor IX Complex, Human (Profilnine) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.220 | Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.215 | Factor VIII (Human, Recombinant) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.216 | Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.222 | Factor XIII A-Subunit, Recombinant (Tretten) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.221 | Factor XIII, Human (Corifact) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.456 | Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.581 | Faricimab-svoa (Vabysmo) (PDF) Effective Date: 5/1/2025 |
CP.PMN.57 | Febuxostat (Uloric) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.613 | Fecal Microbiota, Live-jslm (Rebyota) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.632 | Fecal Microbiota Spores, Live-brpk (Vowst) (PDF) |
CP.PHAR.442 | Fedratinib (Inrebic) (PDF) |
CP.PMN.246 | Fenfluramine (Fintepla) (PDF) |
CP.PMN.127 | Fentanyl IR (Actiq, Fentora, Lazanda, Subsys) (PDF) |
CP.PHAR.234 | Ferric Carboxymaltose (Injectafer) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.480 | Ferric Derisomaltose (Monoferric) (PDF) |
CP.PMN.213 | Ferric Maltol (Accrufer) (PDF) |
CP.PHAR.624 | Ferric Pyrophosphate (Triferic, Triferic Avnu) (PDF) |
CP.PHAR.165 | Ferumoxytol (Feraheme) (PDF) Effective Date: 5/1/2025 |
CP.PMN.289 | Fezolinetant (Veozah) (PDF) |
CP.PHAR.526 | Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF) |
CP.PHAR.643 | Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) |
CP.PHAR.297 | Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko) (PDF) |
CP.PMN.266 | Finerenone (Kerendia) (PDF) |
CP.PCH.38 | Fingolimod (Gilenya, Tascenso ODT) (PDF) |
CP.PHAR.446 | Flibanserin (Addyi) (PDF) |
CP.PMN.165 | Fluorouracil Cream (Tolak) (PDF) |
CP.PMN.95 | Fluticasone propionate (Xhance) (PDF) |
CP.PHAR.226 | Fondaparinux (Arixtra) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.471 | Fosdenopterin (Nulibry) (PDF) |
CP.PHAR.24 | Fostamatinib (Tavalisse) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.516 | Fostemsavir (Rukobia) (PDF) Effective Date: 3/1/2025 |
HIM.PA.SP66 | Fremanezumab-vfrm (Ajovy) (PDF) |
CP.PHAR.666 | Fruquintinib (Fruzaqla) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.424 | Fulvestrant (Faslodex Injection) (PDF) |
CP.PHAR.608 | Furosemide (Furoscix) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.604 | Futibatinib (Lytgobi) (PDF) Effective Date: 5/1/2025 |
CP.PMN.240 | Gabapentin ER (Gralise, Horizant) (PDF)External Link |
HIM.PA.SP67 | Galcanezumab-gnlm (Emgality) (PDF) |
CP.PHAR.161 | Galsulfase (Naglazyme) (PDF) |
CP.PMN.278 | Ganaxolone (Ztalmy) (PDF) |
CP.PHAR.68 | Gefitinib (Iressa) (PDF) |
CP.PHAR.358 | Gemtuzumab Ozogamicin (Mylotarg) (PDF) |
CP.PMN.292 | Gepirone (Exxua) (PDF) |
CP.PHAR.412 | Gilteritinib (Xospata) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.644 | Givinostat (Duvyzat) (PDF) |
CP.PHAR.457 | Givosiran (Givlaari) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.413 | Glasdegib (Daurismo) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.252 | Glatiramer Acetate (Copaxone, Glatopa) (PDF) |
CP.PMN.286 | Glaucoma Agents (PDF) Effective Date: 5/1/2025 |
HIM.PA.SP36 | Glecaprevir/Pibrentasvir (Mavyret) (PDF) |
CP.PHAR.636 | Glofitamab-gxbm (Columvi) (PDF) |
HIM.PA.53 | GLP-1 receptor agonists (PDF) Effective Date: 3/1/2025 |
CP.PHAR.207 | Glycerol Phenylbutyrate (Ravicti) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.453 | Golodirsen (Vyondys 53) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.171 | Goserelin Acetate (Zoladex) (PDF) |
CP.PMN.74 | Granisetron (Sancuso, Sustol) (PDF) |
HIM.PA.20 | Halcinonide (Halog) (PDF) |
CP.PMN.180 | Halobetasol Propionate (Bryhali, Lexette, Ultravate) (PDF) |
CP.PMN.208 | Halobetasol Propionate/Tazarotene (Duobrii) (PDF) |
CP.PHAR.181 | Hemin (Panhematin) (PDF)External Link Effective Date: 3/1/2025 |
CP.PHAR.172 | Histrelin Acetate (Vantas, Supprelin LA) (PDF) |
CP.PMN.111 | House Dust Mite Allergen Extract (Odactra) (PDF) |
HIM.PA.161 | Human Growth Hormone (Somapacitan, Somatrogon, Somatropin, Lonapegsomatropin-tcgd) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.05 | Hyaluronate Derivatives (PDF) |
CP.PHAR.14 | Hydroxyprogesterone Caproate (Makena/compound) (PDF) |
CP.PMN.193 | Hydroxyurea (Siklos, Xromi) (PDF) |
CP.PHAR.378 | Ibalizumab-uiyk (Trogarzo) (PDF) |
CP.PHAR.189 | Ibandronate Injection (Boniva) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.126 | Ibrutinib (Imbruvica) (PDF) Effective Date: 5/1/2025 |
CP.PMN.120 | Ibuprofen/Famotidine (Duexis) (PDF) |
CP.PHAR.178 | Icatibant (Firazyr) (PDF) |
CP.PMN.187 | Icosapent Ethyl (Vascepa) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.481 | Idecabtagene Vicleucel (Abecma) (PDF) |
CP.PHAR.133 | Idelalisib (Zydelig) (PDF) |
CP.PHAR.156 | Idursulfase (Elaprase) (PDF) |
CP.PMN.32 | Iloperidone (Fanapt) (PDF) |
CP.PHAR.193 | Iloprost (Ventavis) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.65 | Imatinib (Gleevec, Imkeldi) (PDF) |
CP.PHAR.690 | Imetelstat (Rytelo) (PDF) |
CP.PHAR.154 | Imiglucerase (Cerezyme) (PDF) |
CP.PHAR.103 | Immune Globulins (PDF) |
CP.PHAR.702 | Inavolisib (Itovebi) (PDF) |
CP.PHAR.568 | Inclisiran (Leqvio) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.231 | IncobotulinumtoxinA (Xeomin) (PDF) |
CP.PHAR.458 | Inebilizumab-cdon (Uplizna) (PDF) |
CP.PHAR.131 | Infertility and Fertility Preservation (PDF) |
CP.PHAR.547 | Infigratinib (Truseltiq) (PDF) |
HIM.PA.153 | Inhaled Agents for Asthma and COPD (PDF) Effective Date: 3/1/2025 |
CP.PHAR.405 | Inotersen (Tegsedi) (PDF) |
CP.PHAR.359 | Inotuzumab Ozogamicin (Besponsa) (PDF) |
CP.PHAR.534 | Insulin Delivery Systems (V-Go, Omnipod, InPen) Effective Date: 3/1/2025 |
HIM.PA.171 | Insulin Detemir (Levemir) (PDF) |
HIM.PA.09 | Insulin Glargine (Rezvoglar, Semglee, Toujeo) (PDF) |
CP.PHAR.52 | Interferon Gamma- 1b (Actimmune) (PDF)External Link Effective Date: 5/1/2025 |
CP.PHAR.255 | Interferon Beta-1a (Avonex, Rebif) (PDF) |
CP.PCH.46 | Interferon Beta-1b (Betaseron, Extavia) (PDF) |
CP.PHAR.459 | Iobenguane I-131 (Azedra) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.319 | Ipilimumab (Yervoy) (PDF) |
CP.PHAR.656 | Iptacopan (Fabhalta) (PDF)External Link |
CP.PHAR.304 | Irinotecan Liposome (Onivyde) (PDF) |
CP.PHAR.482 | Isatuximab-irfc (Sarclisa) (PDF) |
CP.PMN.154 | Isavuconazonium (Cresemba) (PDF) |
CP.PMN.143 | Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) (PDF) |
CP.PMN.217 | Istradefylline (Nourianz) (PDF) Effective Date: 3/1/2025 |
CP.PMN.124 | Itraconazole (Sporanox, Tolsura) (PDF) |
CP.PMN.70 | Ivabradine (Corlanor) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.210 | Ivacaftor (Kalydeco) (PDF) Effective Date: 3/1/2025 |
CP.PMN.269 | Ivermectin (Stromectol, Sklice) (PDF) |
CP.PHAR.137 | Ivosidenib (Tibsovo) (PDF) |
CP.PHAR.302 | Ixazomib (Ninlaro) (PDF) |
CP.PMN.296 | Ketamine (Ketalar) (PDF)External Link |
CP.PMN.282 | Ketorolac Nasal Spray (Sprix) (PDF) |
HIM.PA.172 | Lanadelumab-fylo (Takhzyro) (PDF) |
CP.PHAR.391 | Lanreotide (Somatuline Depot and Unbranded) (PDF) |
CP.PHAR.391 | Lanreotide (Somatuline Depot) (PDF) |
CP.PHAR.79 | Lapatinib (Tykerb) (PDF) |
CP.PHAR.152 | Laronidase (Aldurazyme) (PDF) |
CP.PHAR.414 | Larotrectinib (Vitrakvi) (PDF) Effective Date: 5/1/2025 |
CP.PMN.218 | Lasmiditan (Reyvow) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.695 | Lazertinib (Lazcluze) (PDF) |
CP.PHAR.704 | Lebrikizumab-lbkz (Ebglyss) (PDF) |
CP.PHAR.596 | Lecanemab-irmb (Leqembi) (PDF) |
HIM.PA.SP3 | Ledipasvir/Sofosbuvir (Harvoni) (PDF) |
CP.PMN.219 | Lefamulin (Xenleta) (PDF) |
CP.PHAR.622 | Lenacapavir (Sunlenca) (PDF) |
CP.PHAR.71 | Lenalidomide (Revlimid) (PDF) |
CP.PHAR.597 | Leniolisib (Joenja) (PDF)External Link |
CP.PHAR.138 | Lenvatinib (Lenvima) (PDF) |
CP.PHAR.367 | Letermovir (Prevymis) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.173 | Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) |
CP.PCH.53 | Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF) |
CP.PHAR.682 | Levacetylleucine (Aqneursa) (PDF) Effective Date: 3/1/2025 |
CP.PMN.267 | Levodopa Inhalation Powder (Inbrija) (PDF) |
CP.PMN.275 | Levoketoconazole (Recorlev) (PDF) |
CP.PHAR.151 | Levoleucovorin (Fusilev, Khapzory) (PDF) |
HIM.PA.125 | Levomilnacipran (Fetzima) (PDF) |
CP.PMN.116 | L-glutamine (Endari) (PDF) (PDF) |
CP.PMN.08 | Lidocaine Transdermal (Lidoderm, ZTlido) (PDF) |
CP.PHAR.598 | Lifileucel (Amtagvi) (PDF) |
CP.PMN.73 | Lifitegrast (Xiidra) (PDF) Effective Date: 5/1/2025 |
CP.PMN.27 | Linezolid (Zyvox) (PDF) |
CP.PHAR.483 | Lisocabtagene Maraleucel (Breyanzi) (PDF) |
CP.PMN.152 | Lofexidine (Lucemyra) (PDF) |
CP.PHAR.507 | Lomustine (Gleostine) (PDF) |
CP.PHAR.499 | Lonafarnib (Zokinvy) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.539 | Loncastuximab Tesirine-lpyl (Zynlonta) (PDF) |
CP.PMN.279 | Long-term Antibiotic Treatment for Tick-borne Diseases (PDF) |
CP.PHAR.406 | Lorlatinib (Lorbrena) (PDF) |
CP.PMN.260 | Loteprednol etabonate (Eysuvis) (PDF) Effective Date: 5/1/2025 |
CP.PMN.291 | Lotilaner (Xdemvy) (PDF) |
CP.PHAR.627 | Lovotibeglogene Autotemcel (Lyfgenia) (PDF) Effective Date: 3/1/2025 |
CP.PMN.142 | Lubiprostone (Amitiza) (PDF) |
CP.PMN.166 | Luliconazole Cream (Luzu) (PDF)External Link Effective Date: 3/1/2025 |
CP.PHAR.213 | Lumacaftor/Ivacaftor (Orkambi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.473 | Lumasiran (Oxlumo) (PDF) Effective Date: 5/1/2025 |
CP.PMN.232 | Lumateperone (Caplyta) (PDF) |
CP.PHAR.500 | Lurbinectedin (Zepzelca) (PDF) |
CP.PHAR.450 | Luspatercept-aamt (Reblozyl) (PDF)External Link Effective Date: 5/1/2025 |
CP.PHAR.407 | Lusutrombopag (Mulpleta) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.384 | Lutetium Lu 177 Dotatate (Lutathera) (PDF) |
CP.PHAR.582 | Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF) |
CP.PHAR.194 | Macitentan (Opsumit) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.518 | Mannitol (Bronchitol) (PDF)External Link |
CP.PHAR.543 | Maralixibat (Livmarli) (PDF) |
CP.PHAR.522 | Margetuximab-cmkb (Margenza) (PDF) Effective Date: 5/1/2025 |
CP.PMN.271 | Maribavir (Livtencity) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.674 | Marstacimab-hncq (Hympavzi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.674 | Marstacimab-hncq (Hympavzi) (PDF) Effective Date: 3/1/2025 |
CP.PMN.272 | Mavacamten (Camzyos) (PDF) |
CP.PHAR.679 | Mavorixafor (Xolremdi) (PDF) |
CP.PMN.136 | Mecamylamine (Vecamyl) (PDF) |
CP.PHAR.150 | Mecasermin (Increlex) (PDF) |
CP.PHAR.381 | Mechlorethamine Gel (Valchlor) (PDF) |
CP.PMN.179 | Megestrol Acetate (Megace ES) (PDF) |
CP.PHAR.653 | Melphalan (Hepzato) (PDF) |
CP.PHAR.535 | Melphalan flufenamide (Pepaxto) (PDF) |
CP.PCH.30 | Memantine ER (Namenda XR), Memantine/Donepezil (Namzaric) (PDF) |
HIM.PA.175
| Mepolizumab (Nucala) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.447 | Mercaptopurine (Purixan) (PDF) |
CP.PMN.72 | Metformin ER (Fortamet, Glumetza) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.134 | Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) |
HIM.PA.17 | Methoxsalen (Uvadex) (PDF) |
CP.PHAR.238 | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) (PDF) |
CP.PMN.169 | Methylnaltrexone Bromide (Relistor) (PDF)External Link |
CP.PMN.252 | Metoclopramide (Gimoti) (PDF) |
CP.PHAR.425 | Metreleptin (Myalept) (PDF) |
CP.PMN.211 | Midazolam (Nayzilam) (PDF) |
CP.PHAR.344 | Midostaurin (Rydapt) (PDF) |
CP.PHAR.101 | Mifepristone (Korlym) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.394 | Migalastat (Galafold) (PDF) |
CP.PHAR.164 | Miglustat (Zavesca) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.164 | Miglustat (Zavesca) (PDF) |
CP.PMN.125 | Milnacipran (Savella) (PDF) |
CP.PMN.80 | Minocycline ER (Emrosi, Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) |
CP.PHAR.617 | Mirvetuximab Soravatansine-gynx (Elahere) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.558 | Mitapivat (Pyrukynd) (PDF) |
CP.PHAR.495 | Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) |
CP.PHAR.258 | Mitoxantrone (PDF) |
CP.PHAR.559 | Mobocertinib (Exkivity) (PDF) |
CP.PMN.39 | Modafinil (Provigil) (PDF) |
CP.PHAR.139 | Mogamulizumab-kpkc (Poteligeo) (PDF) |
CP.PHAR.654 | Momelotinib (Ojjaara) (PDF) |
HIM.PA.93 | Mometasone (Nasonex) (PDF) |
CP.PHAR.448 | Mometasone Furoate (Sinuva) (PDF) |
CP.PHAR.618 | Mosunetuzumab-axgb (Lunsumio) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.655 | Motixafortide (Aphexda) (PDF) |
CP.PHAR.398 | Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) |
CP.PMN.287 | Nabumetone Double-Strength (Relafen DS) (PDF) |
CP.PHAR.461 | Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF)External Link |
CP.PHAR.174 | Nafarelin Acetate (Synarel) (PDF) |
CP.PMN.112 | Naldemedine (Symproic) (PDF) |
CP.PHAR.638 | Nalmefene (Opvee) (PDF) |
HIM.PA.167 | Naloxegol (Movantik) (PDF) |
CP.PHAR.96 | Naltrexone (Vivitrol) (PDF) Effective Date: 5/1/2025 |
HIM.PA.130 | Naproxen Oral Suspension (Naprosyn) (PDF) |
CP.PMN.117 | Naproxen/Esomeprazole (Vimovo) (PDF) |
CP.PHAR.259 | Natalizumab (Tysabri, Tyruko) (PDF) |
CP.PHAR.523 | Naxitamab-gqgk (Danyelza) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.320 | Necitumumab (Portrazza) (PDF)Nedosiran (Rivfloza) |
CP.PHAR.619 | Nedosiran (Rivfloza) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.703 | Nemolizumab-ito (Nemluvio) (PDF) Effective Date: 3/1/2025 |
CP.PMN.167 | Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) |
CP.PHAR.365 | Neratinib (Nerlynx) (PDF) |
CP.PMN.158 | Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) (PDF) |
CP.PMN.256 | Nifurtimox (Lampit) (PDF) |
CP.PHAR.76 | Nilotinib (Tasigna, Danziten) (PDF) |
CP.PCH.54 | Nintedanib (Ofev) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.645 | Niraparib + Abiraterone (Akeega) (PDF) |
CP.PHAR.408 | Niraparib (Zejula) (PDF) Effective Date: 5/1/2025 |
CP.PMN.288 | Nirmatrelvir and Ritonavir (Paxlovid) (PDF)External Link |
CP.PHAR.671 | Nirogacestat (Ogsiveo) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.121 | Nivolumab (Opdivo) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.614 | Nirsevimab-alip (Beyfortus) (PDF) |
HIM.PA.152 | Nitazoxanide (Alinia) (PDF) |
CP.PHAR.132 | Nitisinone (Nityr, Orfadin) (PDF) |
CP.PHAR.588 | Nivolumab and Relatlimab-rmbw (Opdualag) (PDF) |
HIM.PA.33 | No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) |
CP.PHAR.684 | Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF) |
CP.PMN.04 | Non-Calcium Phosphate Binders (PDF) Effective Date: 3/1/2025 |
HIM.PA.100 | Non-Formulary and Formulary Contraceptives (PDF) |
HIM.PA.34 | Non-Formulary Test Strips (PDF) Effective Date: 3/1/2025 |
CP.PHAR.327 | Nusinersen (Spinraza) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.675 | Obecabtagene autoleucel (Aucatzyl) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.287 | Obeticholic Acid (Ocaliva) (PDF) |
CP.PHAR.305 | Obinutuzumab (Gazyva) (PDF)Ocrelizumab (Ocrevus) |
CP.PHAR.335 | Ocrelizumab (Ocrevus) (PDF) |
CP.PHAR.40 | Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Mycapssa) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.528 | Odevixibat (Bylvay) (PDF) |
CP.PHAR.306 | Ofatumumab (Arzerra, Kesimpta) (PDF) |
HIM.PA.154 | Off-Label Drug Use (PDF) |
CP.PHAR.292 | Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) |
CP.PMN.265 | Olanzapine/Samidorphan (Lybalvi) (PDF) |
CP.PHAR.360 | Olaparib (Lynparza) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.615 | Olutasidenib (Rezlidhia) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.108 | Omacetaxine (Synribo) (PDF) |
CP.PMN.188 | Omadacycline (Nuzyra) (PDF) |
CP.PCH.49 | Omalizumab (Xolair) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.590 | Omaveloxolone (Skyclarys) (PDF) |
CP.PHAR.232 | OnabotulinumtoxinA (Botox) (PDF) |
CP.PHAR.421 | Onasemnogene Abeparvovec (Zolgensma) (PDF) |
CP.PMN.45 | Ondansetron (Zuplenz) (PDF) |
HIM.PA.03 | Ophthalmic Corticosteroids (PDF) |
CP.PHAR.536 | Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) |
CP.PMN.245 | Opicapone (Ongentys) (PDF) |
HIM.PA.139 | Opioid Analgesics (PDF) |
CP.PHAR.487 | Osilodrostat (Isturisa) (PDF) |
CP.PHAR.294 | Osimertinib (Tagrisso) (PDF) |
CP.PMN.168 | Ospemifene (Osphena) (PDF) |
CP.PMN.198 | Overactive Bladder Agents (PDF) |
CP.PMN.86 | Oxymetazoline (Rhofade, Upneeq) (PDF) |
CP.PHAR.462 | Ozanimod (Zeposia) (PDF) |
CP.PMN.119 | Ozenoxacin (Xepi) (PDF) |
CP.PHAR.176 | Paclitaxel, Protein-Bound (Abraxane) (PDF) |
CP.PHAR.583 | Pacritinib (Vonjo) (PDF) |
HIM.PA.173 | Palbociclib (Ibrance) (PDF) |
CP.PHAR.291 | Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF) |
CP.PHAR.16 | Palivizumab (Synagis) (PDF) |
CP.PHAR.696 | Palopegteriparatide (Yorvipath) (PDF) |
CP.PHAR.548 | Palovarotene (Sohonos) (PDF) |
CP.PCH.44 | Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) |
CP.PHAR.321 | Panitumumab (Vectibix) (PDF) |
CP.PHAR.395 | Patisiran (Onpattro) (PDF) |
CP.PHAR.382 | Panobinostat (Farydak) (PDF) |
CP.PHAR.282 | Parathyroid Hormone (Natpara) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.270 | Paricalcitol Injection (Zemplar) (PDF) |
CP.PHAR.332 | Pasireotide (Signifor, Signifor LAR) (PDF) |
CP.PMN.205 | Patiromer (Veltassa) (PDF) |
CP.PHAR.81 | Pazopanib (Votrient) (PDF) |
CP.PMN.220 | Peanut Allergen Powder-dnfp (Palforzia) (PDF) |
CP.PHAR.353 | Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) |
CP.PHAR.524 | Pegcetacoplan (Empaveli, Syfovre) (PDF) |
CP.PHAR.296 | Pegfilgrastim (Neulasta and biosimilars) (PDF) |
CP.PHAR.89 | Peginterferon Alfa-2a (Pegasys) (PDF) |
CP.PHAR.271 | Peginterferon Beta-1a (Plegridy) (PDF) |
CP.PHAR.115 | Pegloticase (Krystexxa) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.512 | Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF) |
CP.PHAR.140 | Pegvaliase-pqpz (Palynziq) (PDF) |
CP.PHAR.389 | Pegvisomant (Somavert) (PDF) |
CP.PHAR.322 | Pembrolizumab (Keytruda) (PDF) |
CP.PHAR.368 | Pemetrexed (Alimta, Pemfexy) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.496 | Pemigatinib (Pemazyre) (PDF) |
CP.PCH.09 | Penicillamine (Cuprimine) (PDF) |
CP.PMN.156 | Perampanel (Fycompa) (PDF) |
CP.PMN.290 | Perfluorohexyloctane (Miebo) (PDF) |
CP.PHAR.227 | Pertuzumab (Perjeta) (PDF) |
CP.PHAR.501 | Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF) |
CP.PHAR.436 | Pexidartinib (Turalio) (PDF) |
CP.PCH.47 | Phendimetrazine (PDF) |
CP.PCH.13 | Phentermine (Adipex-P, Lomaira) (PDF) |
CP.PMN.270 | Pilocarpine (Qlosi, Vuity) (PDF) |
CP.PMN.140 | Pimavanserin (Nuplazid) (PDF) |
CP.PHAR.286 | Pirfenidone (Esbriet) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.620 | Pirtobrutinib (Jaypirca) (PDF) |
CP.PMN.221 | Pitolisant (Wakix) (PDF) |
CP.PHAR.513 | Plasminogen, Human-tvmh (Ryplazim) (PDF) |
CP.PMN.87 | Plecanatide (Trulance) (PDF) |
CP.PHAR.323 | Plerixafor (Mozobil) (PDF) |
CP.PHAR.433 | Polatuzumab Vedotin-piiq (Polivy) (PDF) |
CP.PHAR.116 | Pomalidomide (Pomalyst) (PDF) |
CP.PHAR.112 | Ponatinib (Iclusig) (PDF) |
CP.PHAR.537 | Ponesimod (Ponvory) (PDF) |
HIM.PA.143 | Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.626 | Pozelimab-bbfg (Veopoz) (PDF) |
CP.PHAR.313 | Pralatrexate (Folotyn) (PDF) (PDF) |
CP.PMN.129 | Pramlintide (Symlin) (PDF) Effective Date: 3/1/2025 |
CP.PMN.99 | Prasterone (Intrarosa) (PDF) Effective Date: 3/1/2025 |
CP.PMN.33 | Pregabalin (Lyrica, Lyrica CR) (PDF) |
CP.PMN.222 | Pretomanid (PDF) Effective Date: 3/1/2025 |
CP.PMN.243 | Progesterone (Crinone, Endometrin, Milprosa) (PDF) |
CP.PCH.51 | Propranolol HCl Oral Solution (Hemangeol) (PDF) |
CP.PHAR.330 | Protein C Concentrate, Human (Ceprotin) (PDF) Effective Date: 3/1/2025 |
HIM.PA.159 | Prucalopride (Motegrity) (PDF) Effective Date: 5/1/2025 |
CP.PMN.44 | Pyrimethamine (Daraprim) (PDF) |
CP.PMN.59 | Quantity Limit Override and Dose Optimization (PDF) |
CP.PMN.64 | Quetiapine Extended-Release (Seroquel XR) (PDF) Effective Date: 5/1/2025 |
CP.PMN.262 | Quinine Sulfate (Qualaquin) (PDF) |
CP.PHAR.646 | Quizartinib (Vanflyta) (PDF) |
CP.PHAR.119 | Ramucirumab (Cyramza) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.186 | Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF) Effective Date: 5/1/2025 |
HIM.PA.89 | Rasagiline (Azilect) (PDF) |
CP.PHAR.415 | Ravulizumab-cwvz (Ultomiris) (PDF) |
CP.PHAR.107 | Regorafenib (Stivarga) (PDF) |
CP.PHAR.529 | Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF) |
HIM.PA.168 | Repository Corticotropin Injection (Acthar Gel, Purified Cortrophin Gel) (PDF) |
CP.PHAR.667 | Repotrectinib (Augtyro) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.223 | Reslizumab (Cinqair) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.647 | Resmetirom (Rezdiffra) (PDF) |
CP.PHAR.658 | Respiratory syncytial virus vaccine (Abrysvo) (PDF)External Link |
CP.PHAR.629 | Retifanlimab-dlwr (Zynyz) (PDF) |
CP.PHAR.707 | Revumenib (Revuforj) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.141 | Ribavirin (Rebetol, Ribasphere RibaPak) (PDF) |
CP.PHAR.334 | Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) (PDF) |
CP.PMN.223 | Rifabutin (Mycobutin) (PDF) Effective Date: 3/1/2025 |
CP.PMN.196 | Rifamycin (Aemcolo) (PDF) |
CP.PMN.47 | Rifaximin (Xifaxan) (PDF) |
CP.PHAR.266 | Rilonacept (Arcalyst) (PDF) |
CP.PHAR.233 | RimabotulinumtoxinB (Myobloc) (PDF) |
CP.PHAR.490 | Rimegepant (Nurtec ODT) (PDF) |
CP.PHAR.195 | Riociguat (Adempas) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.477 | Risdiplam (Evrysdi) (PDF) Effective Date: 3/1/2025 |
CP.PMN.100 | Risedronate (Actonel, Atelvia) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.293 | Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF) |
CP.PHAR.260 | Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF) |
CP.PMN.46 | Roflumilast (Daliresp, Zoryve) (PDF) |
CP.PMN.102 | Rolapitant (Varubi) (PDF) |
CP.PHAR.314 | Romidepsin (Istodax) (PDF) |
CP.PHAR.179 | Romiplostim (Nplate) (PDF) Effective Date: |
CP.PHAR.428 | Romosozumab-aqqg (Evenity) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.570 | Ropeginterferon Alfa-2b-njft (BESREMi) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.648 | Rozanolixizumab-noli (Rystiggo) (PDF) |
CP.PHAR.35 | Rucaparib (Rubraca) (PDF) Effective Date: 5/1/2025 |
CP.PMN.157 | Rufinamide (Banzel) (PDF) |
CP.PHAR.98 | Ruxolitinib (Jakafi, Opzelura) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.475 | Sacituzumab Govitecan-hziy (Trodelvy) (PDF) |
CP.PCH.52 | Sacubitril/Valsartan (Entresto) (PDF) Effective Date: 3/1/2025 |
CP.PMN.113 | Safinamide (Xadago) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.43 | Sapropterin Dihydrochloride (Kuvan) (PDF0 |
CP.PMN.189 | Sarecycline (Seysara) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.295 | Sargramostim (Leukine) (PDF) |
CP.PHAR.463 | Satralizumab-mwge (Enspryng) (PDF) |
CP.PHAR.159 | Sebelipase Alfa (Kanuma) (PDF) |
CP.PMN.103 | Secnidazole (Solosec) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.698 | Seladelpar (Livdelzi) (PDF) |
CP.PHAR.196 | Selexipag (Uptravi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.431 | Selinexor (Xpovio) (PDF) |
CP.PHAR.464 | Selumetinib (Koselugo) (PDF) Effective Date: 5/1/2025 |
CP.PMN.295 | Semaglutide (Wegovy) (PDF) |
CP.PHAR.491 | Setmelanotide (Imcivree) (PDF) Effective Date: 3/1/2025 |
HIM.PA.91 SGLT2 | SGLT2 inhibitors (PDF) Effective Date: 3/1/2025 |
CP.PMN.83 | Short Ragweed Pollen Allergen Extract (Ragwitek) (PDF) |
CP.PCH.07 | Sildenafil for ED (Viagra) (PDF) |
CP.PHAR.197 | Sildenafil (Revatio, Liqrev) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.329 | Siltuximab (Sylvant) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.427 | Siponimod (Mayzent) (PDF) |
CP.PHAR.120 | Sipuleucel-T (Provenge) (PDF) |
CP.PHAR.574 | Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF) Effective Date: 5/1/2025 |
CP.PMN.42 | Sodium Oxybate (Xyrem, Lumryz) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (PDF) |
CP.PHAR.208 | Sodium Phenylbutyrate (Buphenyl, Pheburane, Olpruva) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.584 | Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (PDF) |
CP.PMN.163 | Sodium Zirconium Cyclosilicate (Lokelma) (PDF) |
HIM.PA.91 | Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (PDF) |
CP.PHAR.610 | Sodium Thiosulfate (Pedmark) (PDF) Effective Date: 5/1/2025 |
HIM.PA.SP2 | Sofosbuvir (Sovaldi) (PDF) |
HIM.PA.SP1 | Sofosbuvir/Velpatasvir (Epclusa) (PDF) |
HIM.PA.SP63 | Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (PDF) |
CP.PMN.209 | Solriamfetol (Sunosi) (PDF) |
CP.PHAR.272 | Sonidegib (Odomzo) (PDF) |
CP.PHAR.69 | Sorafenib (Nexavar) (PDF) |
CP.PHAR.657 | Sotatercept (Winrevair) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.549 | Sotorasib (Lumakras) (PDF) |
CP.PHAR.631 | Sparsentan (Filspari) (PDF) |
CP.PHAR.606 | Spesolimab-sbzo (Spevigo) (PDF) |
HIM.PA.134 | Spinosad (Natroba) (PDF) |
HIM.PA.109 | Step Therapy (PDF) |
CP.PMN.184 | Stiripentol (Diacomit) (PDF) |
CP.PHAR.73 | Sunitinib (Sutent) (PDF) |
CP.PHAR.503 | Sutimlimab-jome (Enjaymo) (PDF) |
CP.PMN.109 | Suvorexant (Belsomra) (PDF) |
CP.PMN.85 | Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) (PDF) |
CP.PHAR.198 | Tadalafil (Adcirca, Alyq, Tadliq) (PDF) Effective Date: 3/1/2025 |
CP.PMN.132 | Tadalafil BPH - ED (Cialis) (PDF) |
CP.PHAR.432 | Tafamidis (Vyndaqel, Vyndamax) (PDF) |
CP.PHAR.508 | Tafasitamab-cxix (Monjuvi) (PDF) |
CP.PHAR.409 | Talazoparib (Talzenna) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.157 | Taliglucerase Alfa (Elelyso) (PDF) |
CP.PHAR.542 | Talimogene laherepvec (Imlygic) (PDF) |
CP.PHAR.649 | Talquetamab-tgvs (Talvey) (PDF) |
CP.PMN.283 | Tapinarof (Vtama) (PDF)External Link |
CP.PHAR.685 | Tarlatamab-dlle (Imdelltra) (PDF) |
CP.PMN.104 | Tasimelteon (Hetlioz, Hetlioz LQ) (PDF) Effective Date: 3/1/2025 |
CP.PMN.105 | Tavaborole (Kerydin) (PDF) Effective Date: 3/1/2025 |
CP.PMN.244 | Tazarotene (Arazlo, Fabior, Tazorac) (PDF) |
CP.PHAR.452 | Tazemetostat (Tazverik) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.575 | Tebentafusp-tebn (Kimmtrak) (PDF) |
CP.PHAR.611 | Teclistamab-cqyv (Tecvayli) (PDF) Effective Date: 5/1/2025 |
CP.PMN.62 | Tedizolid (Sivextro) (PDF) |
CP.PHAR.114 | Teduglutide (Gattex) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.337 | Telotristat Ethyl (Xermelo) (PDF) |
CP.PHAR.77 | Temozolomide (Temodar) (PDF) |
CP.PHAR.324 | Temsirolimus (Torisel) (PDF) |
HIM.PA.174 | Tenapanor (Ibsrela, Xphozah) (PDF) Effective Date: 3/1/2025 |
CP.PMN.268 | Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) |
CP.PHAR.492 | Teplizumab-mzwv (Tzield) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.530 | Tepotinib (Tepmetko) (PDF) |
CP.PHAR.465 | Teprotumumab (Tepezza) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.188 | Teriparatide (Forteo, Bonsity) (PDF) Effective Date: 3/1/2025 |
CP.PCH.40 | Teriflunomide (Aubagio) (PDF) |
CP.PHAR.109 | Tesamorelin (Egrifta SV) (PDF) |
HIM.PA.87 | Testosterone (Androderm) (PDF) |
CP.PHAR.354 | Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) |
CP.PHAR.92 | Tetrabenazine (Xenazine) (PDF) |
CP.PHAR.377 | Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) (PDF) |
HIM.PA.176 | Tezepelumab (Tezspire) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.78 | Thalidomide (Thalomid) (PDF) |
CP.PHAR.437 | Thioguanine (Tabloid) (PDF) |
CP.PHAR.95 | Thyrotropin Alfa (Thyrogen) (PDF)External Link |
CP.PMN.84 | Timothy Grass Pollen Allergen Extract (Grastek) (PDF) |
CP.PCH.50 | Tiopronin Delayed-Release (Thiola EC) (PDF) |
CP.PHAR.361 | Tisagenlecleucel (Kymriah) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.686 | Tislelizumab-jsgr (Tevimbra) (PDF) |
CP.PMN.298 | Tirzepatide (Zepbound) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.561 | Tisotumab Vedotin-tftv (Tivdak) (PDF) |
CP.PHAR.538 | Tivozanib (Fotivda) (PDF) |
CP.PHAR.211 | Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (PDF) |
CP.PHAR.591 | Tofersen (Qalsody) (PDF) |
CP.PHAR.27 | Tolvaptan (Jynarque, Samsca) (PDF) |
HIM.PA.71 | Topical Acne Treatment (PDF) |
CP.PMN.107 | Topical Immunomodulators (PDF) Effective Date: 3/1/2025 |
CP.PMN.281 | Topiramate Extended-Release (Qudexy XR, Trokendi XR) (PDF)External Link |
CP.PHAR.64 | Topotecan (Hycamtin) (PDF) |
CP.PHAR.668 | Toripalimab-tpzi (Loqtorzi) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.687 | Tovorafenib (Ojemda) (PDF) |
CP.PHAR.204 | Trabectedin (Yondelis) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.577 | Tralokinumab-ldrm (Adbry) (PDF) |
CP.PHAR.240 | Trametinib (Mekinist) (PDF) |
CP.PHAR.228 | Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF) |
CP.PHAR.672 | Travoprost Implant (iDose TR) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.612 | Tremelimumab-actl (Imjudo) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.199 | Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.371 | Triamcinolone ER Injection (Zilretta) (PDF) Effective Date: 5/1/2025 |
CP.PMN.207 | Triclabendazole (Egaten) (PDF) |
CP.PHAR.438 | Trientine (Cuvrior, Syprine) (PDF)External Link |
CP.PMN.225 | Trifarotene (Aklief) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.383 | Trifluridine/Tipiracil (Lonsurf) (PDF) |
CP.PHAR.509 | Triheptanoin (Dojolvi) (PDF) |
CP.PHAR.175 | Triptorelin Pamoate (Trelstar, Triptodur) (PDF) |
CP.PHAR.600 | Trofineatide (Daybue) (PDF) |
CP.PHAR.497 | Tucatinib (Tukysa) (PDF)External Link |
CP.PHAR.621 | Ublituximab-xiiy (Briumvi) (PDF) |
CP.PMN.277 | Ulcer Therapy Products (Omeclamox Pak, Pylera, Talicia, Voquezna) (PDF) |
CP.PHAR.531 | Umbralisib (Ukoniq) (PDF) |
HIM.PA.SP55 | Uridine Triacetate (Vistogard) (PDF) |
CP.PHAR.677 | Vadadustat (Vafseo) (PDF) |
CP.PCH.48 | Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF) |
CP.PCH.06 | Valganciclovir (Valcyte) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.466 | Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.439 | Valrubicin (Valstar) (PDF) |
CP.PHAR.659 | Vamorolone (Agamree) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.80 | Vandetanib (Caprelsa) (PDF) Effective Date: 3/1/2025 |
CP.PMN.273 | Varenicline (Tyrvaya) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.163 | Velaglucerase Alfa (VPRIV) (PDF) |
CP.PHAR.601 | Velmanase Alfa-tycv (Lamzede) (PDF) |
CP.PHAR.91 | Vemurafenib (Zelboraf) (PDF) Effective Date: |
CP.PHAR.129 | Venetoclax (Venclexta) (PDF) |
CP.PHAR.187 | Verteporfin (Visudyne) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.374 | Vestronidase Alfa-vjbk (Mepsevii) (PDF) |
CP.PHAR.169 | Vigabatrin (Sabril) (PDF) |
CP.PMN.264 | Viloxazine (Qelbree) (PDF) |
CP.PHAR.484 | Viltolarsen (Viltepso) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.273 | Vismodegib (Erivedge) (PDF) |
CP.PHAR.504 | Voclosporin (Lupkynis) (PDF) |
HIM.PA.146 | Vorapaxar (Zontivity) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.699 | Vorasidenib (Voranigo) (PDF) |
CP.PHAR.372 | Voretigene Neparvovec-rzyl (Luxturna) (PDF)External Link Effective Date: 3/1/2025 |
CP.PHAR.83 | Vorinostat (Zolinza) (PDF) |
CP.PMN.65 | Vortioxetine (Trintellix) (PDF) |
CP.PHAR.525 | Vosoritide (Voxzogo) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.451 | Voxelotor (Oxbryta) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.550 | Vutrisiran (Amvuttra) (PDF) |
CP.PMN.299 | Xanomeline-trospium chloride (Cobenfy) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.709 | Zanidatamab-hrii (Ziihera) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.467 | Zanubrutinib (Brukinsa) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.630 | Zavegepant (Zavzpret) (PDF) |
CP.PHAR.713 | Zenocutuzumab-zbco (Bizengri) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.616 | Zilucoplan (Zilbrysq) (PDF) Effective Date: 3/1/2025 |
CP.PHAR.325 | Ziv-aflibercept (Zaltrap) (PDF) |
CP.PHAR.705 | Zolbetuximab-clzb (Vyloy) (PDF) |
CP.PHAR.59 | Zoledronic Acid (Reclast) (PDF) Effective Date: 5/1/2025 |
CP.PHAR.650 | Zuranolone (Zurzuvae) (PDF) |